# Alberto Ortíz

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/alberto-ortiz/

## Facts

| Field | Value |
| --- | --- |
| Citations | 215,030 |
| Field | Chronic Kidney Disease and Diabetes |
| h-index | 128 |
| i10-index | 805 |
| Last Known Institution | Universidad de Cádiz |
| OpenAlex ID | https://openalex.org/A5063245254 |
| ORCID iD | 0000-0002-9805-9523 |
| Works | 1,492 |

## Researcher papers

Showing 12 of 14.

- [Chronic kidney disease and the global public health agenda: an international consensus](https://scholariq.org/papers/chronic-kidney-disease-and-the-global-public-health-agenda-an-international/)
- [Fabry disease revisited: Management and treatment recommendations for adult patients](https://scholariq.org/papers/fabry-disease-revisited-management-and-treatment-recommendations-for-adult/)
- [The systemic nature of CKD](https://scholariq.org/papers/the-systemic-nature-of-ckd/)
- [Epidemiology, contributors to, and clinical trials of mortality risk in chronic kidney failure](https://scholariq.org/papers/epidemiology-contributors-to-and-clinical-trials-of-mortality-risk-in-chronic/)
- [Chronic kidney disease is a key risk factor for severe COVID-19: a call to action by the ERA-EDTA](https://scholariq.org/papers/chronic-kidney-disease-is-a-key-risk-factor-for-severe-covid-19-a-call-to-action/)
- [Lipid management in patients with chronic kidney disease](https://scholariq.org/papers/lipid-management-in-patients-with-chronic-kidney-disease/)
- [Early detection of diabetic kidney disease by urinary proteomics and subsequent intervention with spironolactone to delay progression (PRIORITY): a prospective observational study and embedded randomised placebo-controlled trial](https://scholariq.org/papers/early-detection-of-diabetic-kidney-disease-by-urinary-proteomics-and-subsequent/)
- [Recommendations for the use of tolvaptan in autosomal dominant polycystic kidney disease: a position statement on behalf of the ERA-EDTA Working Groups on Inherited Kidney Disorders and European Renal Best Practice](https://scholariq.org/papers/recommendations-for-the-use-of-tolvaptan-in-autosomal-dominant-polycystic-kidney/)
- [Diagnosis and Prediction of CKD Progression by Assessment of Urinary Peptides](https://scholariq.org/papers/diagnosis-and-prediction-of-ckd-progression-by-assessment-of-urinary-peptides/)
- [The STARMEN trial indicates that alternating treatment with corticosteroids and cyclophosphamide is superior to sequential treatment with tacrolimus and rituximab in primary membranous nephropathy](https://scholariq.org/papers/the-starmen-trial-indicates-that-alternating-treatment-with-corticosteroids-and/)
- [Hypertension in dialysis patients: a consensus document by the European Renal and Cardiovascular Medicine (EURECA-m) working group of the European Renal Association–European Dialysis and Transplant Association (ERA-EDTA) and the Hypertension and the Kidney working group of the European Society of Hypertension (ESH)*](https://scholariq.org/papers/hypertension-in-dialysis-patients-a-consensus-document-by-the-european-renal-and/)
- [SGLT-2 inhibitors and GLP-1 receptor agonists for nephroprotection and cardioprotection in patients with diabetes mellitus and chronic kidney disease. A consensus statement by the EURECA-m and the DIABESITY working groups of the ERA-EDTA](https://scholariq.org/papers/sglt-2-inhibitors-and-glp-1-receptor-agonists-for-nephroprotection-and/)

## Researcher topics

- [Chronic Kidney Disease and Diabetes](https://scholariq.org/topics/chronic-kidney-disease-and-diabetes/)
- [Dialysis and Renal Disease Management](https://scholariq.org/topics/dialysis-and-renal-disease-management/)
- [Renal Diseases and Glomerulopathies](https://scholariq.org/topics/renal-diseases-and-glomerulopathies/)
- [Acute Kidney Injury Research](https://scholariq.org/topics/acute-kidney-injury-research/)
- [Parathyroid Disorders and Treatments](https://scholariq.org/topics/parathyroid-disorders-and-treatments/)

## Researcher university

- [Universidad de Cádiz](https://scholariq.org/institutions/universidad-de-cadiz/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.